Quest Diagnostics (DGX) FCF Payout Ratio Growth (1y) (2010 - 2026)
Quest Diagnostics (DGX) FCF Payout Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -51.90% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 13.17% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -45.25% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | 487.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 487.26% |
| Dec 31, 2025 | 2,769.44% |
| Sep 30, 2025 | 106.53% |
| Jun 30, 2025 | -95.55% |
| Mar 31, 2025 | -58.47% |
| Dec 31, 2024 | 0.07% |
| Sep 30, 2024 | -501.72% |
| Jun 30, 2024 | 519.21% |
| Mar 31, 2024 | 109.81% |
| Dec 31, 2023 | -97.34% |
| Sep 30, 2023 | 122.46% |
| Jun 30, 2023 | -16.07% |
| Mar 31, 2023 | -1,363.64% |
| Dec 31, 2022 | 478.09% |
| Sep 30, 2022 | -84.89% |
| Jun 30, 2022 | -282.62% |
| Mar 31, 2022 | 294.69% |
| Dec 31, 2021 | 260.82% |
| Sep 30, 2021 | 361.06% |
| Jun 30, 2021 | -76.77% |